Interleukin-5: From Molecule to Drug Target for AsthmaThis important volume describes the latest advances in all areas of interleukin-5 (IL5) research, pooling the insights of over 65 biological researchers, pharmaceutical scientists, and clinicians, representing institutions as diverse as the Mayo Clinic, the National Lung and Heart Institute, the John Curtin School of Medical Research, the Geneva Biomedical Research Institute, the Flanders' Interuniversity Institute for Biotechnology, and the University of Tokyo. Details IL5-related antiallergy drugs currently in development at Glaxo Wellcome and Schering-Plough Research Institute! Reviewing approaches toward small molecule antagonists and inhibitors, Interleukin-5 Featuring over 1250 references, tables, drawings, photographs, and micrographs, Interleukin-5 is suitable for pulmonologists and pulmonary disease specialists; immunologists; clinical allergists; internists; chest, intensive care, primary care, and family practice physicians; respiratory therapists; physiologists; pathologists; cell and molecular biologists; and medical school students in these disciplines. |
